Search results for “Membranous nephropathy” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 133 patents, we discovered top 37 key players by total patent application. Silence Therapeutics GmbH, Teijin Pharma Ltd., EUROIMMUN Medizinische Labordiagnostika AG are dominant in this area. They take 37.59% of the total patent filing.
Silence Therapeutics GmbH
Berlin, Germany
Patent: 20
Teijin Pharma Ltd.
Tokyo-to, Japan
Patent: 17
EUROIMMUN Medizinische Labordiagnostika AG
Schleswig-Holstein, Germany
Patent: 13
Principia Biopharma, Inc.
California, United States
Patent: 12
Centre National De La Recherche Scientif
France
Patent: 10
Genentech, Inc.
California, United States
Patent: 9
Genzyme Corp.
Massachusetts, United States
Patent: 8
Incyte Corp.
Delaware, United States
Patent: 4
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 4
Amgen, Inc.
California, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 123 patents applied in the last 5 years. We discover 41 most active companies in this area. The fast-growing Silence Therapeutics GmbH, Teijin Pharma Ltd., Principia Biopharma, Inc. take 39.84% of patent filing during this period.
Silence Therapeutics GmbH
Berlin, Germany
Patent: 20
Teijin Pharma Ltd.
Tokyo-to, Japan
Patent: 17
Principia Biopharma, Inc.
California, United States
Patent: 12
EUROIMMUN Medizinische Labordiagnostika AG
Schleswig-Holstein, Germany
Patent: 8
Genentech, Inc.
California, United States
Patent: 8
Mayo Foundation for Medical Education & Research
Minnesota, United States
Patent: 7
Centre National De La Recherche Scientif
France
Patent: 3
Foshan No. 1 People's Hospital
Guangdong Sheng, China
Patent: 2
Peking University First Hospital
Beijing Shi, China
Patent: 2
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 123 patents in last 5 years, we discover 38 new entrants. Silence Therapeutics GmbH, Teijin Pharma Ltd., Principia Biopharma, Inc. are the most active new entrants in this area.
Silence Therapeutics GmbH
Berlin, Germany
Patent: 20
Teijin Pharma Ltd.
Tokyo-to, Japan
Patent: 17
Principia Biopharma, Inc.
California, United States
Patent: 12
Mayo Foundation for Medical Education & Research
Minnesota, United States
Patent: 7
Foshan No. 1 People's Hospital
Guangdong Sheng, China
Patent: 2
Peking University First Hospital
Beijing Shi, China
Patent: 2
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
Université Côte dAzur
France
Patent: 2
MorphoSys AG
Bayern, Germany
Patent: 2
Zhejiang Boshi Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 47 patents, we discovered top 9 universities and scientific research institutions by total patent application. University of Nice Sophia Antipolis, Tokai University, Université Côte dAzur are dominant in this area. They take 74.47% of the total patent filing.
University of Nice Sophia Antipolis
France
Patent: 7
Tokai University
Tokyo-to, Japan
Patent: 2
Université Côte dAzur
France
Patent: 2
Northwestern University
Illinois, United States
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
University of Miyazaki
Miyazaki-ken, Japan
Patent: 1
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Harbin Medical University
Heilongjiang Sheng, China
Patent: 1
Southeast University
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: